Study of perennial allergic rhinitis - Long term treatment study.
Phase of Trial: Phase III
Latest Information Update: 05 Sep 2018
At a glance
- Drugs Fluticasone furoate (Primary)
- Indications Perennial allergic rhinitis
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 28 Oct 2010 Actual end date (Oct 2005) added as reported by ClinicalTrials.gov.
- 04 Nov 2006 New trial record.